l-glutathione reduced molecular weight reduced, 70-18-8, G4251, Sigma-Aldrich L-Glutathione Reduced 250 mg |

Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment

For injection use only

Current Research Limitations Most clinical studies on GHK-Cu involve: Topical formulations In vitro research Animal models Systemic (non-injectable) delivery There is insufficient evidence in peer-reviewed literature to support: standardized injection techniques validated injectable dosing regimens long-term safety or efficacy data for injectable use As a result, clinicians should approach injectable discussions with caution and rely on evidence-based peptide education rather than anecdotal protocols

Oral treatment reduced proliferation and TNF- generation in mice, and EGCG prevented TRAIL-induced neuronal injury in living brain tissue [125]

It's not a new ingredient, it has been used both as a food and cosmetics additive since the 1970s